Sarepta Price Target Slashed To $0 At H.C. Wainwright As Stock Plunge Continues
Shares of Sarepta dropped as much as 11% in premarket trading and remain down about 6% after the cash open this morning.
The decline follows H.C. Wainwright’s reiteration of its Sell rating and a drastic cut in its price target—from $10 to $0—after the FDA requested Sarepta voluntarily withdraw its ELEVIDYS gene therapy from the market. Sarepta has reportedly declined to comply.
The FDA’s request follows a third liver-related death linked to the company’s gene therapy programs—two associated with ELEVIDYS and one from a separate LGMD subtype trial.
Sarepta shares have already plunged more than 90% over the past year, now trading at $14.08, down from a 52-week high of $150.48. According to Bloomberg, the stock now holds 7 Buy, 16 Hold, and 3 Sell ratings.
H.C. Wainwright raised concerns over Sarepta’s deteriorating commercial outlook, noting that its non-ELEVIDYS franchise is expected to decline, with 2025 revenue guidance of $900 million, down 6% year-over-year. Its LGMD2E asset, while still in development, addresses a very small patient population—estimated at just 250 cases annually.
Financially, Sarepta faces mounting pressure: it holds $1.1 billion in convertible debt due in 2027, against $850 million in cash.
Sarepta has refused a request from the U.S. Food and Drug Administration to halt all shipments of its gene therapy Elevidys after three patient deaths, we reported this weekend. The FDA disclosed that two teenage boys with Duchenne muscular dystrophy, both unable to walk, died recently from acute liver failure after receiving Elevidys. In addition, a 51-year-old participant in a trial of a different Sarepta gene therapy targeting limb-girdle muscular dystrophy died last month, also of acute liver failure. Bloomberg writes that following these events, FDA officials met with Sarepta and asked the company to voluntarily pause shipments of Elevidys, which accounts for more than half the company’s product revenue. “The company refused to do so,” the agency stated. The stock indicates that the prevailing sentiment seems to be that the FDA may pull Sarepta’s drug off the market…
Tyler Durden Mon, 07/21/2025 – 10:25
Source: https://freedombunker.com/2025/07/21/sarepta-price-target-slashed-to-0-at-h-c-wainwright-as-stock-plunge-continues/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
| Visits: | 1,711,474,292 |
| Stories: | 8,457,586 |
Whistler Blowers, Insiders
